Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) [Phase 3]

View source ↗

Summary

Phase 3 study to evaluate safety and efficacy of Larsucosterol in participants with alcohol-associated hepatitis; trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Larsucosterol (Larsucosterol)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Hepatitis | Phase 3 | Status: RECRUITING